
|Articles|April 15, 2008
Lexiscan approved as new cardiac stress test agent
Regadenoson receives FDA approval as first A2A adenosine receptor agonist for myocardial perfusion imaging.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
3
Q&A: Pharmacists Help Patients Navigate Pneumococcal Vaccine Options
4
Pharmacists Are Essential Drivers of Opioid Stewardship Programs
5






























